Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00496067
Status:
TERMINATED
Last Update Posted:
2011-03-09
First Post:
2007-07-03
Brief Title:
Uterine Artery Occlusion for Fibroid Related Bleeding
Sponsor:
Ethicon Inc
Organization:
Ethicon Inc
Study Overview
Official Title:
An Evaluation of a Doppler-Guided Uterine Artery Occlusion Device as Treatment for the Reduction of Fibroid-Associated Bleeding
Status:
TERMINATED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Data required further pilot work to be undertaken
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to evaluate the safety and effectiveness of Doppler guided Uterine Artery Occlusion D-UAO as treatment for the reduction of fibroid-associated symptoms
Detailed Description:
DUAO is intended for bilateral occlusion of the uterine arteries
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None